US health regulators greenlight a new kind of nerve stimulator for congestion
What happened
US health regulators have created a new regulatory category for a device that uses electricity to relieve nasal congestion. This means companies can now bring these devices to market more easily, as they no longer need to go through the most rigorous approval process.
Why it matters
Before this, any new electrical nerve stimulator for congestion would have faced the highest level of regulatory scrutiny, a slow and expensive process. Now, companies can get these devices approved by meeting specific safety and effectiveness controls, which is a much faster path. This change could lead to more options for people with chronic congestion, as it lowers the barrier for new products to enter the market.
The signal
Watch for new transcutaneous electrical nerve stimulators for congestion to appear on the market within the next 12-24 months, and whether they are marketed directly to consumers.